Status:
COMPLETED
Chlorhexidine Disk for Prevention of Exit-site Infection in Peritoneal Dialysis Patients
Lead Sponsor:
Singapore General Hospital
Collaborating Sponsors:
Johnson & Johnson
Conditions:
Peritoneal Dialysis Catheter Exit Site Infection
Eligibility:
All Genders
21-90 years
Phase:
NA
Brief Summary
The purpose of the study is to evaluate the efficacy and safety of chlorhexidine-impregnated disk in preventing catheter exit-site infection in peritoneal dialysis patients
Detailed Description
The primary aim of the study is to examine the exit-site infection rate in patients using chlorhexidine-impregnated dressing. The participant will be followed up at 2, 6, 12, 24, 36 and 52 weeks of s...
Eligibility Criteria
Inclusion
- All adult incident peritoneal dialysis patients between 21 to 90 years old, who are followed up in Singapore General Hospital
Exclusion
- patients who have known history of allergy to chlorhexidine
- patients who had previous history of peritoneal dialysis catheter exit-site infection
- patients with mentally challenging conditions who are unable to give the valid consent for the study
- patients who have been involved in another study for exit site infection
Key Trial Info
Start Date :
March 7 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 25 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03406520
Start Date
March 7 2018
End Date
October 25 2019
Last Update
March 23 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Singapore General Hospital
Singapore, Singapore, 169856